In contrast, in infantile hemangiomas, vascular tumours that affect 5–10% of all infants, Iso has been shown to increase the proliferation of hemangioma-derived ECs and increased VEGF expression (Ji et al., 2013). The gene discussed is VEGFA; the disease is vascular neoplasm.